Barrows Brian R, Parks Elizabeth J
Center for Human Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9052, USA.
J Clin Endocrinol Metab. 2006 Apr;91(4):1446-52. doi: 10.1210/jc.2005-1709. Epub 2006 Jan 31.
The liver's regulation of fatty acids (FAs) postprandially may contribute to risk of metabolic diseases.
Measurements of steady-state metabolism were used to investigate sources of FAs used for very low-density lipoprotein (VLDL)-triacylglycerol (TG) synthesis during fasting and feeding in vivo.
DESIGN/INTERVENTION: Subjects were duodenally fed a formula labeled with the stable isotope glyceryl tri-palmitate-d(31) and iv infused with [1,2,3,4-(13)C(4)]-palmitatic acid and [1-(13)C(1)]-acetate to quantitate the liver's use of FAs originating from adipose tissue and de novo lipogenesis.
SETTING/PARTICIPANTS: This study of healthy men (n = 12; body mass index, 24.4 +/- 2.7 kg/m(2)) was conducted at a General Clinical Research Center.
Concentrations of metabolites during fasting and feeding, sources of FAs used for lipoprotein synthesis, rate of appearance of serum nonesterified FA (NEFA), and VLDL-TG were measured.
During fasting, 77.2 +/- 14.0% of VLDL-TG was derived from adipose FA recycling and 4.0 +/- 3.6% from lipogenesis; with feeding, 43.6 +/- 18.6% came from adipose FAs (P < 0.001), 8.2 +/- 5.1% from lipogenesis (P < 0.001), 15.2 +/- 13.7% from uptake of chylomicron-remnant TG, and 10.3 +/- 6.9% from dietary FA spillover into the serum NEFA pool. Fed-state VLDL-TG from NEFA reesterification decreased in proportion to the reduction in adipose NEFA appearance.
These data: 1) quantify the extent to which the healthy liver manages its use of different sources of FAs that flow to it, 2) demonstrate how the postprandial reduction in adipose-NEFA flux may be partially replaced by other sources, and 3) highlight the potential for dietary FA spillover to support the continued dominance of NEFA as a substrate for VLDL-TG synthesis.
肝脏餐后对脂肪酸(FAs)的调节可能会增加代谢性疾病的风险。
通过稳态代谢测量来研究在体内禁食和进食期间用于极低密度脂蛋白(VLDL)-三酰甘油(TG)合成的脂肪酸来源。
设计/干预措施:受试者经十二指肠给予标记有稳定同位素甘油三棕榈酸酯-d(31)的配方,并静脉输注[1,2,3,4-(13)C(4)]-棕榈酸和[1-(13)C(1)]-乙酸盐,以定量肝脏对源自脂肪组织和从头脂肪生成的脂肪酸的利用情况。
地点/参与者:这项针对健康男性(n = 12;体重指数,24.4±2.7 kg/m²)的研究在一个综合临床研究中心进行。
测量禁食和进食期间的代谢物浓度、用于脂蛋白合成的脂肪酸来源、血清非酯化脂肪酸(NEFA)的出现率以及VLDL-TG。
在禁食期间,77.2±14.0%的VLDL-TG来自脂肪脂肪酸循环利用,4.0±3.6%来自脂肪生成;进食后,43.6±18.6%来自脂肪脂肪酸(P < 0.001),8.2±5.1%来自脂肪生成(P < 0.001),15.2±13.7%来自乳糜微粒残粒TG的摄取,10.3±6.9%来自膳食脂肪酸溢出到血清NEFA池中。由NEFA重新酯化产生的进食状态下的VLDL-TG与脂肪NEFA出现量的减少成比例下降。
这些数据:1)量化了健康肝脏对流入其的不同脂肪酸来源的利用程度;2)证明了餐后脂肪-NEFA通量的减少如何可能部分地被其他来源所取代;3)突出了膳食脂肪酸溢出支持NEFA作为VLDL-TG合成底物持续占主导地位的潜力。